Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. [electronic resource]
- European journal of heart failure Feb 2008
- 149-56 p. digital
Aged Angiotensin II Type 1 Receptor Blockers--therapeutic use Atrial Fibrillation--epidemiology Biphenyl Compounds--therapeutic use Body Mass Index Diabetic Angiopathies--epidemiology Female Heart Failure--drug therapy Humans Irbesartan Male Stroke Volume Tetrazoles--therapeutic use